vs
CSX Corporation（CSX）与TENET HEALTHCARE CORP（THC）财务数据对比。点击上方公司名可切换其他公司
TENET HEALTHCARE CORP的季度营收约是CSX Corporation的1.6倍（$5.5B vs $3.5B），CSX Corporation净利率更高（23.2% vs 11.7%，领先11.5%），TENET HEALTHCARE CORP同比增速更快（9.0% vs 1.7%），CSX Corporation自由现金流更多（$793.0M vs $367.0M），过去两年TENET HEALTHCARE CORP的营收复合增速更高（1.5% vs -3.0%）
CSX运输是美国一级货运铁路企业，业务覆盖美国东部区域及加拿大安大略省、魁北克省，运营铁路总里程约3.4万公里，隶属于总部位于佛罗里达州杰克逊维尔市的财富500强企业CSX Corporation，是其旗下核心子公司。
Tenet Healthcare Corporation是总部位于美国达拉斯的营利性跨国医疗服务企业，旗下拥有USPI等多个品牌、子公司、合资企业及合作主体，运营65家医院及超过450个医疗设施，还通过旗下Conifer Health Solutions为各类医疗系统及其他客户提供专业医疗支持服务
CSX vs THC — 直观对比
营收规模更大
THC
是对方的1.6倍
$3.5B
营收增速更快
THC
高出7.2%
1.7%
净利率更高
CSX
高出11.5%
11.7%
自由现金流更多
CSX
多$426.0M
$367.0M
两年增速更快
THC
近两年复合增速
-3.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $3.5B | $5.5B |
| 净利润 | $807.0M | $644.0M |
| 毛利率 | — | — |
| 营业利润率 | 29.9% | 15.4% |
| 净利率 | 23.2% | 11.7% |
| 营收同比 | 1.7% | 9.0% |
| 净利润同比 | 401.2% | 12.6% |
| 每股收益（稀释后） | — | $4.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CSXTHC
| Q1 26 | $3.5B | — | ||
| Q4 25 | $3.5B | $5.5B | ||
| Q3 25 | $3.6B | $5.3B | ||
| Q2 25 | $3.6B | $5.3B | ||
| Q1 25 | $3.4B | $5.2B | ||
| Q4 24 | $3.5B | $5.1B | ||
| Q3 24 | $3.6B | $5.1B | ||
| Q2 24 | $3.7B | $5.1B |
净利润CSXTHC
| Q1 26 | $807.0M | — | ||
| Q4 25 | $720.0M | $644.0M | ||
| Q3 25 | $694.0M | $579.0M | ||
| Q2 25 | $829.0M | $522.0M | ||
| Q1 25 | $646.0M | $622.0M | ||
| Q4 24 | $720.0M | $572.0M | ||
| Q3 24 | $894.0M | $681.0M | ||
| Q2 24 | $963.0M | $477.0M |
营业利润率CSXTHC
| Q1 26 | 29.9% | — | ||
| Q4 25 | 31.6% | 15.4% | ||
| Q3 25 | 30.3% | 16.8% | ||
| Q2 25 | 35.9% | 15.6% | ||
| Q1 25 | 30.4% | 18.1% | ||
| Q4 24 | 30.8% | 16.2% | ||
| Q3 24 | 37.4% | 21.3% | ||
| Q2 24 | 39.1% | 14.9% |
净利率CSXTHC
| Q1 26 | 23.2% | — | ||
| Q4 25 | 20.5% | 11.7% | ||
| Q3 25 | 19.3% | 10.9% | ||
| Q2 25 | 23.2% | 9.9% | ||
| Q1 25 | 18.9% | 11.9% | ||
| Q4 24 | 20.3% | 11.3% | ||
| Q3 24 | 24.7% | 13.3% | ||
| Q2 24 | 26.0% | 9.3% |
每股收益（稀释后）CSXTHC
| Q1 26 | — | — | ||
| Q4 25 | $0.39 | $4.22 | ||
| Q3 25 | $0.37 | $3.86 | ||
| Q2 25 | $0.44 | $3.14 | ||
| Q1 25 | $0.34 | $4.27 | ||
| Q4 24 | $0.38 | $3.79 | ||
| Q3 24 | $0.46 | $4.89 | ||
| Q2 24 | $0.49 | $2.64 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.1B | $2.9B |
| 总债务越低越好 | $18.9B | $13.1B |
| 股东权益账面价值 | $13.6B | $4.2B |
| 总资产 | $44.2B | $29.7B |
| 负债/权益比越低杠杆越低 | 1.39× | 3.10× |
8季度趋势，按日历期对齐
现金及短期投资CSXTHC
| Q1 26 | $1.1B | — | ||
| Q4 25 | $5.0M | $2.9B | ||
| Q3 25 | $6.0M | $3.0B | ||
| Q2 25 | $6.0M | $2.6B | ||
| Q1 25 | $8.0M | $3.0B | ||
| Q4 24 | $72.0M | $3.0B | ||
| Q3 24 | $12.0M | $4.1B | ||
| Q2 24 | $4.0M | $2.9B |
总债务CSXTHC
| Q1 26 | $18.9B | — | ||
| Q4 25 | $18.2B | $13.1B | ||
| Q3 25 | $18.6B | $13.1B | ||
| Q2 25 | $18.6B | $13.1B | ||
| Q1 25 | $18.5B | $13.1B | ||
| Q4 24 | $17.9B | $13.1B | ||
| Q3 24 | $18.5B | $12.8B | ||
| Q2 24 | $18.0B | $12.8B |
股东权益CSXTHC
| Q1 26 | $13.6B | — | ||
| Q4 25 | $13.2B | $4.2B | ||
| Q3 25 | $12.8B | $4.0B | ||
| Q2 25 | $12.4B | $3.7B | ||
| Q1 25 | $12.2B | $4.2B | ||
| Q4 24 | $12.5B | $4.2B | ||
| Q3 24 | $12.9B | $3.8B | ||
| Q2 24 | $12.6B | $3.5B |
总资产CSXTHC
| Q1 26 | $44.2B | — | ||
| Q4 25 | $43.7B | $29.7B | ||
| Q3 25 | $43.3B | $29.4B | ||
| Q2 25 | $42.9B | $28.7B | ||
| Q1 25 | $43.2B | $29.2B | ||
| Q4 24 | $42.8B | $28.9B | ||
| Q3 24 | $43.1B | $29.4B | ||
| Q2 24 | $42.4B | $29.3B |
负债/权益比CSXTHC
| Q1 26 | 1.39× | — | ||
| Q4 25 | 1.38× | 3.10× | ||
| Q3 25 | 1.45× | 3.26× | ||
| Q2 25 | 1.50× | 3.49× | ||
| Q1 25 | 1.52× | 3.13× | ||
| Q4 24 | 1.43× | 3.14× | ||
| Q3 24 | 1.43× | 3.33× | ||
| Q2 24 | 1.42× | 3.67× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3B | $731.0M |
| 自由现金流经营现金流 - 资本支出 | $793.0M | $367.0M |
| 自由现金流率自由现金流/营收 | 22.8% | 6.6% |
| 资本支出强度资本支出/营收 | — | 6.6% |
| 现金转化率经营现金流/净利润 | 1.58× | 1.14× |
| 过去12个月自由现金流最近4个季度 | $2.0B | $2.5B |
8季度趋势，按日历期对齐
经营现金流CSXTHC
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.4B | $731.0M | ||
| Q3 25 | $1.3B | $1.1B | ||
| Q2 25 | $635.0M | $936.0M | ||
| Q1 25 | $1.3B | $815.0M | ||
| Q4 24 | $1.4B | $-331.0M | ||
| Q3 24 | $1.7B | $1.0B | ||
| Q2 24 | $1.1B | $747.0M |
自由现金流CSXTHC
| Q1 26 | $793.0M | — | ||
| Q4 25 | $709.0M | $367.0M | ||
| Q3 25 | $607.0M | $778.0M | ||
| Q2 25 | $-141.0M | $743.0M | ||
| Q1 25 | $536.0M | $642.0M | ||
| Q4 24 | $550.0M | $-661.0M | ||
| Q3 24 | $1.1B | $829.0M | ||
| Q2 24 | $547.0M | $602.0M |
自由现金流率CSXTHC
| Q1 26 | 22.8% | — | ||
| Q4 25 | 20.2% | 6.6% | ||
| Q3 25 | 16.9% | 14.7% | ||
| Q2 25 | -3.9% | 14.1% | ||
| Q1 25 | 15.7% | 12.3% | ||
| Q4 24 | 15.5% | -13.0% | ||
| Q3 24 | 29.3% | 16.2% | ||
| Q2 24 | 14.8% | 11.8% |
资本支出强度CSXTHC
| Q1 26 | — | — | ||
| Q4 25 | 19.3% | 6.6% | ||
| Q3 25 | 20.4% | 5.3% | ||
| Q2 25 | 21.7% | 3.7% | ||
| Q1 25 | 21.0% | 3.3% | ||
| Q4 24 | 23.7% | 6.5% | ||
| Q3 24 | 17.3% | 4.2% | ||
| Q2 24 | 14.6% | 2.8% |
现金转化率CSXTHC
| Q1 26 | 1.58× | — | ||
| Q4 25 | 1.93× | 1.14× | ||
| Q3 25 | 1.93× | 1.83× | ||
| Q2 25 | 0.77× | 1.79× | ||
| Q1 25 | 1.94× | 1.31× | ||
| Q4 24 | 1.93× | -0.58× | ||
| Q3 24 | 1.89× | 1.53× | ||
| Q2 24 | 1.13× | 1.57× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CSX
暂无分部数据
THC
| Other | $2.9B | 52% |
| Health Care Patient Service | $1.4B | 25% |
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | $1.2B | 22% |
| Health Care Other Sources | $56.0M | 1% |
